GSK plc

GSK plc Inventory

The Inventory of GSK plc (GSK.L) as of Nov 2, 2026 is 5.92 B GBP. In the previous year, Inventory was 5.67 B GBP — a change of 4.50% (higher).

Inventory

5.92 BGBP

YoY

4.50%

Last updated:

Inventory of GSK plc is 2025 5.92 B GBP. Inventory of GSK plc was 2024 5.67 B GBP. It decreases by 4.50% higher compared to the previous year.

The GSK plc Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
5.48 B GBP
Jan 1, 2019
5.95 B GBP
Jan 1, 2020
6.00 B GBP
Jan 1, 2021
5.78 B GBP
Jan 1, 2022
5.15 B GBP
Jan 1, 2023
5.50 B GBP
Jan 1, 2024
5.67 B GBP
Jan 1, 2025
5.92 B GBP
The GSK plc Inventory history
YEARInventoryYoY
5.92 BGBP+4.50%
5.67 BGBP+3.11%
5.50 BGBP+6.84%
5.15 BGBP-11.02%
5.78 BGBP-3.55%
6.00 BGBP+0.82%
5.95 BGBP+8.60%
5.48 BGBP-1.46%
5.56 BGBP+8.92%
5.10 BGBP+8.18%
4.72 BGBP+11.46%
4.23 BGBP—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

GSK plc Stock analysis

What does GSK plc do? GSK plc generates revenue through its Pharmaceuticals and Vaccines segments, which focus on developing and selling prescription medicines and vaccines. The Pharmaceuticals segment offers products in Respiratory, HIV, Specialty, and Classic and Established categories, targeting acute and chronic diseases. The Vaccines segment provides over 40 vaccines for pediatric, adolescent, adult, and older populations, including travel vaccines. Customers include healthcare providers, hospitals, and consumers purchasing over-the-counter products. GSK's brand portfolio spans prescription medicines like those for Respiratory and HIV, alongside vaccines such as those for pediatric and adult health. The company's research focuses on six therapeutic areas: Respiratory diseases, HIV/infectious diseases, Vaccines, Immuno-inflammation, Oncology, and Rare diseases. This research drives product development for both segments, ensuring a steady pipeline of medicines and vaccines. The company's products are distributed globally, with the Pharmaceuticals business targeting healthcare professionals and the Vaccines business serving public health programs and individual consumers. GSK's strategy emphasizes innovation in key therapeutic areas to address unmet medical needs, leveraging its extensive research and development capabilities to maintain market leadership. GSK plc is one of the most popular companies on Eulerpool.

Frequently Asked Questions about GSK plc stock

Inventory of GSK plc is 5.92 B GBP in 2025.

Inventory of GSK plc changed from 5.67 B GBP to 5.92 B GBP, representing a 4.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory GSK plc since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's GBP is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's GSK plc historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — GSK plc

All Key Metrics — GSK plc